Insider Shareholders with Direct Ownership of Brooklyn Immuno Therapeutics, Inc. (BTX)
This section provides a comprehensive overview of the insiders with direct ownership of Brooklyn Immuno Therapeutics, Inc. (BTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Brooklyn ImmunoTherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Charles Cherington
> 10% Shareholder |
16,333,506 | 400,000 | 16,628,123 $0 | 5 |
Oct 29, 2024
Added 14.5%
|
|
Allen Wolff
Former Director and CEO |
0 | 16,138 | 128,520 $0 | 7 |
Mar 24, 2021
Reduced 7.18%
|
|
Roger Sidhu
Chief Medical Officer |
20,163 | 0 | 20,163 $0 | 1 |
Sep 20, 2022
Added 50.0%
|
|
Kevin D Amour
Chief Scientific Officer |
17,573 | 6,077 | 11,496 $0 | 2 |
Jun 28, 2022
Reduced 34.58%
|
|
Sandra M Gurrola
Sr. VP of Finance |
9,625 | 13,046 | 1,185 $0 | 13 |
Jun 21, 2024
Reduced 13.19%
|